Shopping Cart
- Remove All
- Your shopping cart is currently empty
PDE9-IN-1 is a selective and orally bioavailable Inhibitor of PDE9A(IC50 of 8.7 nM).
Pack Size | Price | Availability | Quantity |
---|---|---|---|
1 mg | $52 | In Stock | |
5 mg | $123 | In Stock | |
10 mg | $198 | In Stock | |
25 mg | $353 | In Stock | |
50 mg | $515 | In Stock | |
1 mL x 10 mM (in DMSO) | $39 | In Stock |
Description | PDE9-IN-1 is a selective and orally bioavailable Inhibitor of PDE9A(IC50 of 8.7 nM). |
Targets&IC50 | PDE9A:8.7 nM |
In vivo | In the Unilateral common carotid artery occlusion (UCCAO) mouse model, PDE9-IN-1 (2.5-5.0 mg/kg; orally) significantly reduces the day 6 escape latency time, increases the frequency of platform area crossings, and recoveres learning and memory function. High dose group possibly improved the escape latency time of mice[1]. |
Molecular Weight | 362.4 |
Formula | C17H23FN6O2 |
Cas No. | 2305087-92-5 |
Smiles | O=C1C2=C(N(N=C2)C3CCCC3)NC(N[C@@H](C(=O)N4CC[C@H](F)C4)C)=N1 |
Relative Density. | 1.58 g/cm3 (Predicted) |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | |||||||||||||||||||||||||||||||||||
Solubility Information | DMSO: 45 mg/mL (124.17 mM) | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
|
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.